You are here :
Moneycontrol »
Markets » Profit & Loss account - GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare
BSE: 500676 | NSE: GSKCONS | ISIN: INE264A01014 | Food Processing
Profit & Loss account of GlaxoSmithKline Consumer Healthcare |
------------------- in Rs. Cr. ------------------- |
|
Dec '04 |
Dec '05 |
Dec '06 |
Dec '07 |
Dec '08 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Income |
|
|
|
|
| Sales Turnover |
987.83 |
1,095.24 |
1,240.62 |
1,429.97 |
1,742.84 |
| Excise Duty |
120.19 |
124.43 |
101.34 |
122.09 |
158.51 |
| Net Sales |
867.64 |
970.81 |
1,139.28 |
1,307.88 |
1,584.33 |
| Other Income |
18.88 |
16.47 |
24.55 |
31.67 |
47.79 |
| Stock Adjustments |
-5.81 |
38.09 |
1.45 |
27.34 |
45.87 |
| Total Income |
880.71 |
1,025.37 |
1,165.28 |
1,366.89 |
1,677.99 |
| Expenditure |
|
|
|
|
| Raw Materials |
306.67 |
352.69 |
387.58 |
471.61 |
633.48 |
| Power & Fuel Cost |
24.85 |
27.34 |
29.93 |
30.44 |
44.24 |
| Employee Cost |
107.56 |
121.45 |
136.38 |
154.94 |
171.95 |
| Other Manufacturing Expenses |
73.31 |
87.58 |
102.47 |
113.41 |
131.64 |
| Selling and Admin Expenses |
183.13 |
202.09 |
247.48 |
270.50 |
323.56 |
| Miscellaneous Expenses |
22.78 |
24.55 |
23.92 |
32.03 |
37.34 |
| Preoperative Exp Capitalised |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Expenses |
718.30 |
815.70 |
927.76 |
1,072.93 |
1,342.21 |
|
Dec '04 |
Dec '05 |
Dec '06 |
Dec '07 |
Dec '08 |
|
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Operating Profit |
143.53 |
193.20 |
212.97 |
262.29 |
287.99 |
| PBDIT |
162.41 |
209.67 |
237.52 |
293.96 |
335.78 |
| Interest |
5.25 |
4.22 |
3.53 |
4.61 |
6.97 |
| PBDT |
157.16 |
205.45 |
233.99 |
289.35 |
328.81 |
| Depreciation |
41.46 |
41.85 |
42.71 |
43.49 |
41.95 |
| Other Written Off |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Profit Before Tax |
115.70 |
163.60 |
191.28 |
245.86 |
286.86 |
| Extra-ordinary items |
0.16 |
3.48 |
0.03 |
0.02 |
0.00 |
| PBT (Post Extra-ord Items) |
115.86 |
167.08 |
191.31 |
245.88 |
286.86 |
| Tax |
42.68 |
58.75 |
63.66 |
82.46 |
95.75 |
| Reported Net Profit |
73.16 |
107.15 |
126.93 |
162.68 |
188.33 |
| Total Value Addition |
411.64 |
463.02 |
540.17 |
601.32 |
708.73 |
| Preference Dividend |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Equity Dividend |
31.77 |
33.64 |
42.06 |
50.47 |
63.08 |
| Corporate Dividend Tax |
4.15 |
4.72 |
5.90 |
8.58 |
10.72 |
| Per share data (annualised) |
|
|
|
|
| Shares in issue (lakhs) |
453.81 |
420.56 |
420.56 |
420.56 |
420.56 |
| Earning Per Share (Rs) |
16.12 |
25.48 |
30.18 |
38.68 |
44.78 |
| Equity Dividend (%) |
70.00 |
80.00 |
100.00 |
120.00 |
150.00 |
| Book Value (Rs) |
116.65 |
112.97 |
129.05 |
153.69 |
180.92 |
|
|
|
|
| Source : Religare Technova |
| Explore GlaxoSmith Con connections |
|
